←News detail

Shanghai ObserverUpdated Oct 31 13:59

A new-generation robotic all-femtosecond refractive diagnosis and treatment device has been deployed at the Ninth People's Hospital North Campus, with a single-eye laser scan of about 10 seconds

AI summary

The North Campus of Shanghai Ninth People's Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, has put into use the first new-generation robotic all-femtosecond refractive diagnosis and treatment device of its series in China, with a single-eye laser scan time of about 10 seconds, significantly shorter than the previous generation. It was officially put into clinical use on October 30. The device is equipped with an integrated laser robotic arm and an eye positioning and navigation system, which can automatically assist in completing eye positioning and rotation compensation, and adds an independent optical high-definition microscope. The hospital said its corneal cutting is more uniform and the duration of negative-pressure fixation is reduced, which helps alleviate postoperative dry eyes and speed up recovery.

Body · AI translation

According to the World Health Organization, the total number of myopia patients in China has reached nearly 600 million. The number of people nationwide undergoing myopia correction surgery continues to grow, and the public's requirements for the safety of myopia correction and postoperative visual experience continue to rise. Minimally invasive SMILE surgery has been in clinical use for more than ten years, and its safety and stability have been clinically verified. The Department of Ophthalmology at Shanghai Ninth People's Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, is a National Key Clinical Specialty and has worked for many years in multiple subspecialties including ocular oncology, orbital diseases, oculoplastic surgery, and corneal refractive surgery. To further meet the regional public's demand for myopia correction diagnosis and treatment and to continuously improve the capacity to supply eye health medical services, Ninth People's Hospital has equipped its North Campus with the first new-generation robotic SMILE refractive diagnosis and treatment device of the same series in China, with a single-eye laser scanning time of about 10 seconds, significantly shorter than the previous generation. On October 30, the device was officially put into clinical use in the Department of Ophthalmology at the North Campus (No. 280 Mohe Road). Chief Physician Guo Tao performing surgery. Guo Tao, deputy director of the Department of Ophthalmology at Ninth People's Hospital and head of ophthalmology at the North Campus, introduced that the device's installation at the North Campus will further enrich the options for clinical techniques in ophthalmic myopia correction and expand clinical diagnosis and treatment choices for people who wish to be free of glasses. After the device is put into use, experts from the ophthalmic refractive team can all perform surgery at the North Campus. The device is equipped with an integrated laser robotic arm and an eye positioning and navigation system. Surgeons can complete laser ablation according to the preoperative examination plan, and the device can automatically assist in completing eye positioning and rotation compensation, ensuring that the ablation position is more centered and more accurate, which is conducive to astigmatism correction, improving nighttime visual performance, and reducing glare, halos, and similar conditions. Chief Physician Zhou Jibo in outpatient clinic. Zhou Jibo, director of the Optometry Center of the Department of Ophthalmology at Ninth People's Hospital, said that this SMILE surgery is iteratively optimized on the basis of traditional SMILE technology. The laser scanning time is further shortened, and the duration of negative-pressure fixation is reduced accordingly, alleviating patients' subjective discomfort during surgery and improving the patient experience. The new-generation device produces a more uniform corneal ablation plane and has less impact on corneal tissue, which helps reduce postoperative dry-eye discomfort and accelerate recovery. Intraoperative stability is improved, and the range of clinically suitable patients is expanded. It is understood that, on the basis of the previous generation, this device adds an independent optical high-definition microscope, allowing doctors to remove the corneal lenticule more clearly under the microscope. This procedure does not create a corneal flap and is flapless and minimally invasive, and can better preserve the biomechanical state of the cornea. Chief Physician Zhang Jing performing surgery. Zhang Jing, a chief physician in the Department of Ophthalmology, has long been engaged in myopia laser correction. She explained that during SMILE surgery, doctors use a laser to cut a thin "corneal lenticule" inside the cornea, and then remove the lenticule through a tiny incision, correcting myopia by changing the shape of the cornea. SMILE laser surgery is a subtractive procedure on the cornea, rather than an additive procedure involving implantation of a lens. Whether subtractive or additive, the fundus structure of myopic eyes remains unchanged, and patients with myopia should still undergo regular fundus examinations. Experts remind that myopia correction surgery is a medical diagnosis and treatment procedure and is not suitable for everyone. Those who wish to be free of glasses must complete a comprehensive and systematic preoperative eye examination, and ophthalmology professionals must make a comprehensive assessment based on eye conditions and overall physical condition to determine whether surgery can be performed and which diagnosis and treatment plan is suitable.

Source

Shanghai Observer